Ultralife - ULBI Stock Forecast, Price & News

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle adapters, vehicle installed power enhanced rifleman appliqué systems, and SATCOM systems. This segment's military communications systems and accessories are designed to enhance and extend the operation of communications equipment, such as vehicle-mounted, manpack, and handheld transceivers. It sells its products under the Ultralife, Ultralife Thin Cell, Utralife HiRate, Ultralife and design, Ultra, Lithium Power, LithiumPower and Design, McDowell Research, AMTI, ABLE, ACCUTRONICS, ACCUPRO, ENTELLION, SWE Southwest Electronic Energy Group, SWE DRILL-DATA, and SWE SEASAFE brands through original equipment manufacturers, and industrial and defense supply distributors, as well as directly to the United States and international defense departments. In addition, the company sells its 9-volt battery to the broader consumer market through national and regional retail chains and online retailers. Ultralife Corporation serves government, defense, and commercial sectors. The company was incorporated in 1990 and is headquartered in Newark, New York.

Ultralife Trading Up 0.4 %

NASDAQ:ULBI opened at $4.62 on Thursday. The company has a debt-to-equity ratio of 0.17, a current ratio of 3.24 and a quick ratio of 1.47. Ultralife has a fifty-two week low of $4.16 and a fifty-two week high of $8.47. The business's 50-day simple moving average is $4.62 and its 200-day simple moving average is $4.92. The stock has a market capitalization of $74.53 million, a PE ratio of -51.33 and a beta of 1.38.

Analyst Upgrades and Downgrades

Separately, StockNews.com began coverage on Ultralife in a research report on Wednesday. They set a "strong-buy" rating for the company.

Insider Buying and Selling at Ultralife

In other Ultralife news, Director Bradford T. Whitmore bought 30,690 shares of Ultralife stock in a transaction on Wednesday, June 8th. The shares were purchased at an average cost of $5.20 per share, with a total value of $159,588.00. Following the acquisition, the director now directly owns 740,353 shares of the company's stock, valued at approximately $3,849,835.60. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Ultralife news, Director Bradford T. Whitmore acquired 30,690 shares of the stock in a transaction on Wednesday, June 8th. The shares were purchased at an average price of $5.20 per share, for a total transaction of $159,588.00. Following the completion of the acquisition, the director now owns 740,353 shares in the company, valued at approximately $3,849,835.60. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Bradford T. Whitmore bought 30,848 shares of the stock in a transaction dated Tuesday, August 2nd. The stock was purchased at an average price of $4.60 per share, with a total value of $141,900.80. Following the acquisition, the director now owns 771,201 shares of the company's stock, valued at $3,547,524.60. The disclosure for this purchase can be found here. Insiders bought a total of 113,870 shares of company stock worth $550,616 over the last three months. Corporate insiders own 40.20% of the company's stock.